Bexagliflozin is an organic compound used as a pharmaceutical raw material. It functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor and is employed in the manufacture of medications for glycemic control in type 2 diabetes.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1118567-05-7
Dapagliflozin Impurity D
reference standard for impurity testing
Dapagliflozina
active pharmaceutical ingredient
Dapagliflozin propanediol
sodium-glucose co-transporter 2 inhibitor
Empagliflozina
sodium-glucose cotransporter 2 inhibitor
Arginine Hydrochloride
active pharmaceutical ingredient
Tetradecyltrimethylammonium bromide
disinfectant and biocide active ingredient
5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl]oxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid
pharmaceutical impurity reference standard
Quetiapina
active pharmaceutical ingredient
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
BTCRKOKVYTVOLU-SJSRKZJXSA-N
C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl